Novita Pharmaceuticals, Inc. ("Novita"), a privately held, clinical-stage pharmaceutical company dedicated to developing novel cancer drugs through its proprietary fascin inhibitor technology, today ...
The maximum tolerated dose and biologic effects of 3-amino-pyridine-2-carboxaldehyde thiosemicarbazone (T) in combination with irinotecan (I) for patients with refractory solid tumors This is an ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results